Clinical & Experimental Cardiology
Open Access

Hernandez Molina D

Publications

• Review Article
  New Pharmacological Opportunities for Prevention of Preeclampsia
  Author(s): García Benavides L*, Hernandez Molina D, Barajas Vega JL, Totsuka Sutto SE, Ramírez Lizardo EJ, and Grover Páez FGarcía Benavides L*, Hernandez Molina D, Barajas Vega JL, Totsuka Sutto SE, Ramírez Lizardo EJ, and Grover Páez F
  
  Preclampsia (PE) is a disorder in the pregnancy, with a worldwide prevalence of 5 to 8 %. Is one of the leading causes of maternal and perinatal morbidity and mortality? Actually exist different diagnostic criteria, however due to the complexity of PE and signs and symptoms that make up this syndrome could be not clearly evident. It has recently been postulated pathophysiology of PE in three pathophysiologic processes: inadequate uterine remodeling, placental dysfunction and maternal endothelial dysfunction. Despite advances in the treatment of PE and decades of research, the results of medical interventions have failed to significantly decrease the morbidity and mortality of this disease. The main reason for this is perhaps the multifactorial origin of pathogenic processes that lead to the development of PE. That is why the approach to patient management .. View More»
  DOI: 10.4172/2155-9880.1000457

  Abstract PDF

Relevant Topics